TARGAZYME INC has a total of 13 patent applications. Its first patent ever was published in 2009. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are BIOVEC LLC, CENTURY BIOSTRENGHTH BEIJING PTY LTD and BOYALIFE INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | Australia | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | Republic of Korea | 1 | |
#7 | Singapore | 1 | |
#8 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Basic materials chemistry |
# | Technology | |
---|---|---|
#1 | Enzymes | |
#2 | Microorganisms | |
#3 | Medical preparations | |
#4 | Preservation of human bodies | |
#5 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Wolpe Stephen D | 6 |
#2 | Wolfe Stephen D | 6 |
#3 | Koh Lynnet | 4 |
#4 | Miller Leonard | 3 |
#5 | Ichim Thomas E | 2 |
#6 | Miller Len | 1 |
Publication | Filing date | Title |
---|---|---|
CA2954534A1 | Manufacture and cryopreservation of fucosylated cells for therapeutic use | |
US2014161782A1 | Augmentation of cell therapy efficacy including treatment with alpha 1-3 fucoslytransferase | |
EP2300599A1 | Augmentation of cell therapy efficacy including treatment with alpha 1-3 fucoslytransferase |